Paronychia Latest Advances
Find the Latest Research About Paronychia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1949 publications
Cutaneous Adverse Events in Children Receiving Mitogen-Activated Protein Kinase Pathway Inhibitors.
Journal: The Australasian journal of dermatology
Published: July 16, 2026
Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.
Journal: Cutaneous and ocular toxicology
Published: July 07, 2026
Characterizing the post-market safety profile of lazertinib: a pharmacovigilance study of the FDA Adverse Events Reporting System Database.
Journal: Investigational new drugs
Published: May 22, 2026
Osimertinib rechallenge using an oral anti-urticarial medication regimen following full body Urticaria: A case report.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 13, 2026
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.
Journal: Thoracic cancer
Published: April 26, 2026
Epidemiological and antibiotic susceptibility pattern of bacterial paronychial infection.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: April 22, 2026
Apremilast for Acrodermatitis Continua of Hallopeau: Report of Two Cases and Review of the Literature.
Journal: The Journal of dermatology
Published: April 20, 2026
Biosynthesized Silver Nanoparticles From Bacillus stercoris 2AT10: Synthesis, Characterization, and Antimicrobial Activity Against Paronychia-Associated Microorganisms.
Journal: International journal of microbiology
Published: April 20, 2026
Last Updated: 09/26/2026